FOLH1 and prostate carcinoma: The prostate-specific membrane antigen (PSMA) is a zinc containing metalloenzyme having a molecular weight of 100 kDa and is overexpressed in the vast majority of prostate cancer cells and in tumor neovasculature [7,8].